Just in Time for the Holidays: FDA’s Updated Guidance on CBD Amid More Warning Letters

FDA Update Despite the impending Thanksgiving holiday, the U.S. Food and Drug Administration (“FDA”) kept plenty busy this week in keeping the hemp industry on its toes issuing: (a) yet another round of a whopping fifteen (15) warning letters to companies purportedly marketing “unapproved new drugs” containing hemp-derived cannabidiol (“CBD”) in violation of FDA regulations;

By |2019-12-06T09:08:12-07:00December 5th, 2019|HLG Blogs|